More than one-third of patients with SSc screened positive for self-reported depression, with GI involvement identified as the most significant predictor.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

Compared to all-cause acute care and the general population, cannabis-related acute care is associated with a higher 5-year dementia risk.

Topical testosterone therapy does not significantly improve functional outcomes beyond supervised exercise training in older women recovering from a hip fracture.

Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.

Female primary care physicians (PCPs) in value-based payment models have equal or better quality outcomes and higher earning than their male counterparts.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The American Academy of Pediatrics presents updated guidance for the treatment of children with atopic dermatitis (AD).

Self-reported cannabis use was not associated with increased postoperative pain in most arthroscopic procedures.

US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025.

Certain air pollutants were associated with changes in metabolites among postmenopausal women in the US, potentially impacting bone health.

While testosterone appeared protective against radiographic knee OA and pain among women, it was correlated with a greater hand OA burden among men.